Following President Trump's executive order, the Indian pharmaceutical industry anticipates a surge in unannounced ...

Story April 14 - Third Harmonic Bio: The California biotech has abandoned plans to take its chronic spontaneous urticaria drug into phase ... Cherokee manufacturing plant in Riverside ...

Innovation, a right to health, and rare disease research – biotechnical drugs for such are what the future is being built on, he said. Already, the effects of the Biotech Centre of Excellence ...

“Where in-vivo (tested in a living body or plant) safety studies are deemed necessary ... plan to phase out animal testing requirements for monoclonal antibodies (biotech drugs) and other therapies, ...

U.S. pharmaceutical companies are increasingly licensing new drugs from China. Former FDA Commissioner Scott Gottlieb ...

In 2021, Sly, biochemistry professor Harry Brumer, and a group of other researchers at the UBC developed GlycoCage, a ...

The meeting was with a startup created by Flatiron Health veterans Josh Haimson and Ben Birnbaum. The duo had built the first ...

Nature Medicine has been chronicling advances in medical technology and health care. To mark the journal’s 30th anniversary, ...

The sector mainly comprises pharma/biotech and medical device companies ... Sales of Obesity Care drugs, Saxenda and Wegovy, are likely to have been encouraging as well. Tampa, FL-based Pacira ...